The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Advances in neuro-oncology imaging
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
Ward, K. M., Aletras, A. H., & Balaban, R. S. (2000) · Journal of Magnetic Resonance · doi:10.1006/jmre.1999.1956 · Cited by 1,429
Ohgaki, H., & Kleihues, P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.479 · Cited by 1,381
Epidemiology of Brain Metastases
Nayak, L., Lee, E. Q., & Wen, P. Y. (2012) · Current Oncology Reports · doi:10.1007/s11912-011-0203-y · Cited by 1,361
Law, M., Yang, S., Wang, H., Babb, J. S., Johnson, G., Cha, S., Knopp, E. A., & Zagzag, D. (2003) · PubMed Central · Cited by 1,084
Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.
Aronen, H. J., Gazit, I. E., Louis, D. N., Buchbinder, B. R., Pardo, F. S., Weisskoff, R. M., Harsh, G. R., Cosgrove, G. R., Halpern, E. F., & Hochberg, F. H. (1994) · Radiology · doi:10.1148/radiology.191.1.8134596 · Cited by 908
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
Choi, C., Ganji, S. K., DeBerardinis, R. J., Hatanpaa, K. J., Rakheja, D., Kovacs, Z., Yang, X.-L., Mashimo, T., Raisanen, J. M., Marin-Valencia, I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2682 · Cited by 839
Albert, N. L., Weller, M., Suchorska, B., Galldiks, N., Soffietti, R., Kim, M. M., la Fougère, C., Pope, W., Law, I., Arbizu, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now058 · Cited by 744
Self-citationHodi, F. S., Hwu, W.-J., Kefford, R., Weber, J. S., Daud, A., Hamid, O., Patnaik, A., Ribas, A., Robert, C., Gangadhar, T. C., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0391 · Cited by 734
Moffat, B. A., Chenevert, T. L., Lawrence, T. S., Meyer, C. R., Johnson, T. D., Dong, Q., Tsien, C., Mukherji, S., Quint, D. J., Gebarski, S. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501532102 · Cited by 643
Pauleit, D. (2005) · Brain · doi:10.1093/brain/awh399 · Cited by 634
Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
Hygino da Cruz, L. C., Rodriguez, I., Domingues, R. C., Gasparetto, E. L., & Sorensen, A. G. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2397 · Cited by 545
Law, M., Young, R. J., Babb, J. S., Peccerelli, N., Chheang, S., Gruber, M. L., Miller, D. C., Golfinos, J. G., Zagzag, D., & Johnson, G. (2008) · Radiology · doi:10.1148/radiol.2472070898 · Cited by 534
In vivo imaging of glucose uptake and metabolism in tumors
Walker-Samuel, S., Ramasawmy, R., Torrealdea, F., Rega, M., Rajkumar, V., Johnson, S. P., Richardson, S., Gonçalves, M., Parkes, H. G., Årstad, E., et al. (2013) · Nature Medicine · doi:10.1038/nm.3252 · Cited by 479
Lev, M. H., Özsunar, Y., Henson, J. W., Rasheed, A. A., Barest, G. D., Harsh, G. R., Fitzek, M. M., Chiocca, E. A., Rabinov, J. D., Csavoy, A. N., et al. (2004) · PubMed · Cited by 474
Clinical Applications of PET in Brain Tumors
Chen, W. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037689 · Cited by 449
Issues of spectral quality in clinical 1H‐magnetic resonance spectroscopy and a gallery of artifacts
Kreis, R. (2004) · NMR in Biomedicine · doi:10.1002/nbm.891 · Cited by 430
Terakawa, Y., Tsuyuguchi, N., Iwai, Y., Yamanaka, K., Higashiyama, S., Takami, T., & Ohata, K. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048082 · Cited by 419
Hu, L. S., Baxter, L. C., Smith, K. A., Feuerstein, B. G., Karis, J. P., Eschbacher, J. M., Coons, S. W., Nakaji, P., Yeh, R. F., Debbins, J., et al. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1377 · Cited by 396
Pseudoprogression and pseudoresponse in the treatment of gliomas
Brandsma, D., & van den Bent, M. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328332363e · Cited by 378
Imaging of Brain Tumors: MR Spectroscopy and Metabolic Imaging
Horská, A., & Barker, P. B. (2010) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2010.04.003 · Cited by 356
Delineation of Brain Tumor Extent with [11C]l-Methionine Positron Emission Tomography
Kracht, L. W., Miletic, H., Busch, S., Jacobs, A. H., Voges, J., Hoevels, M., Klein, J. C., Herholz, K., & Heiss, W.-D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0262 · Cited by 292
Pöpperl, G., Kreth, F. W., Mehrkens, J. H., Herms, J., Seelos, K., Koch, W., Gildehaus, F. J., Kretzschmar, H. A., Tonn, J. C., & Tatsch, K. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0534-y · Cited by 288
Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas.
Castillo, M., Smith, J. K., Kwock, L., & Wilber, K. P. (2001) · PubMed Central · Cited by 267
Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionine
Becherer, A., Karanikas, G., Szab�, M., Zettinig, G., Asenbaum, S., Marosi, C., Henk, C., Wunderbaldinger, P., Czech, T., Wadsak, W., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1259-1 · Cited by 266
Galldiks, N., Dunkl, V., Stoffels, G., Hutterer, M., Rapp, M., Sabel, M., Reifenberger, G., Kebir, S., Dorn, F., Blau, T., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2959-4 · Cited by 266
Self-citationGrosu, A.-L., Astner, S. T., Riedel, E., Nieder, C., Wiedenmann, N., Heinemann, F., Schwaiger, M., Molls, M., Wester, H.-J., & Weber, W. A. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.07.002 · Cited by 253
Patel, P., Baradaran, H., Delgado, D., Askin, G., Christos, P., John Tsiouris, A., & Gupta, A. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now148 · Cited by 250
Hot spots in dynamic18FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas
Kunz, M., Thon, N., Eigenbrod, S., Hartmann, C., Egensperger, R., Herms, J., Geisler, J., la Fougere, C., Lutz, J., Linn, J., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq196 · Cited by 246
Dunet, V., Rossier, C., Buck, A., Stupp, R., & Prior, J. O. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.096859 · Cited by 244
Hutterer, M., Nowosielski, M., Putzer, D., Jansen, N. L., Seiz, M., Schocke, M., McCoy, M., Göbel, G., la Fougère, C., Virgolini, I. J., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos300 · Cited by 239
11C-l-Methionine Positron Emission Tomography in the Clinical Management of Cerebral Gliomas
Singhal, T., Narayanan, T. K., Jain, V., Mukherjee, J., & Mantil, J. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0115-2 · Cited by 227
Galldiks, N., Langen, K.-J., Holy, R., Pinkawa, M., Stoffels, G., Nolte, K. W., Kaiser, H. J., Filss, C. P., Fink, G. R., Coenen, H. H., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098590 · Cited by 204
Self-citationRyken, T. C., Aygun, N., Morris, J., Schweizer, M., Nair, R., Spracklen, C., Kalkanis, S. N., & Olson, J. J. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1330-0 · Cited by 195
Sagiyama, K., Mashimo, T., Togao, O., Vemireddy, V., Hatanpaa, K. J., Maher, E. A., Mickey, B. E., Pan, E., Sherry, A. D., Bachoo, R. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323855111 · Cited by 194
Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
Rapp, M., Heinzel, A., Galldiks, N., Stoffels, G., Felsberg, J., Ewelt, C., Sabel, M., Steiger, H. J., Reifenberger, G., Beez, T., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109603 · Cited by 193
Self-citationFloeth, F. W., Pauleit, D., Wittsack, H.-J., Langen, K. J., Reifenberger, G., Hamacher, K., Messing-Jünger, M., Zilles, K., Weber, F., Stummer, W., et al. (2005) · Journal of Neurosurgery · doi:10.3171/jns.2005.102.2.0318 · Cited by 193
Self-citationO-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours
Weckesser, M., Langen, K., Rickert, C. H., et al. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1705-8 · Cited by 192
Self-citationGalldiks, N., Stoffels, G., Filss, C. P., Piroth, M. D., Sabel, M., Ruge, M. I., Herzog, H., Shah, N. J., Fink, G. R., Coenen, H. H., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.103325 · Cited by 190
Self-citationPöpperl, G., Kreth, F. W., Herms, J. W., Koch, W., Mehrkens, J. H., Gildehaus, F. J., Kretzschmar, H. A., Tonn, J. C., & Tatsch, K. (2006) · PubMed · Cited by 189
Prognostic Value of O-(2-18F-Fluoroethyl)-L-Tyrosine PET and MRI in Low-Grade Glioma
Floeth, F. W., Pauleit, D., Sabel, M., Stoffels, G., Reifenberger, G., Riemenschneider, M. J., Jansen, P., Coenen, H. H., Steiger, H.-J., & Langen, K.-J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037895 · Cited by 186
Self-citationDunet, V., Pomoni, A., Hottinger, A., Nicod-Lalonde, M., & Prior, J. O. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov148 · Cited by 183
Okubo, S., Zhen, H.-N., Kawai, N., Nishiyama, Y., Haba, R., & Tamiya, T. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0117-9 · Cited by 179
Biological tumor volume in 18 FET-PET before radiochemotherapy correlates with survival in GBM
Suchorska, B., Jansen, N. L., Linn, J., Kretzschmar, H., Janssen, H., Eigenbrod, S., Simon, M., Pöpperl, G., Kreth, F. W., la Fougere, C., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001262 · Cited by 172
Galldiks, N., Langen, K.-J., & Pope, W. B. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov118 · Cited by 170
Self-citation11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET
Kim, S., Chung, J.-K., Im, S.-H., Jeong, J. M., Lee, D. S., Kim, D. G., Jung, H., & Lee, M. C. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1598-6 · Cited by 168
Hutterer, M., Nowosielski, M., Putzer, D., Waitz, D., Tinkhauser, G., Kostron, H., Muigg, A., Virgolini, I. J., Staffen, W., Trinka, E., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.086645 · Cited by 168
Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis
Nihashi, T., Dahabreh, I. J., & Terasawa, T. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3324 · Cited by 165
Pope, W. B., Qiao, X. J., Kim, H. J., Lai, A., Nghiemphu, P., Xue, X., Ellingson, B. M., Schiff, D., Aregawi, D., Cha, S., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0847-y · Cited by 160
Andronesi, O. C., Loebel, F., Bogner, W., Marjańska, M., Heiden, M. G. V., Iafrate, A. J., Dietrich, J., Batchelor, T. T., Gerstner, E. R., Kaelin, W. G., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0656 · Cited by 159
Zhang, H., Ma, L., Wang, Q., Zheng, X., Wu, C., & Xu, B. (2014) · European Journal of Radiology · doi:10.1016/j.ejrad.2014.09.018 · Cited by 159
Saraswathy, S., Crawford, F. W., Lamborn, K. R., Pirzkall, A., Chang, S., Cha, S., & Nelson, S. J. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9685-3 · Cited by 158
Wang, S., Martinez-Lage, M., Sakai, Y., Chawla, S., Kim, S. G., Alonso-Basanta, M., Lustig, R. A., Brem, S., Mohan, S., Wolf, R. L., et al. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4474 · Cited by 158
Sadeghi, N., D’Haene, N., Decaestecker, C., Levivier, M., Metens, T., Maris, C., Wikler, D., Balériaux, D., Salmon, I. J., & Goldman, S. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0851 · Cited by 153
Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma
Jansen, N. L., Suchorska, B., Wenter, V., Schmid‐Tannwald, C., Todica, A. S., Eigenbrod, S., Niyazi, M., Tonn, J., Bartenstein, P., Kreth, F.-W., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.144675 · Cited by 153
The role of LAT1 in 18F-DOPA uptake in malignant gliomas
Youland, R. S., Kitange, G. J., Peterson, T. E., Pafundi, D., Ramiscal, J. A. B., Pokorny, J. L., Giannini, C., Laack, N. N. I., Parney, I. F., Lowe, V. J., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0986-1 · Cited by 146
Piroth, M. D., Pinkawa, M., Holý, R., Klotz, J., Nussen, S., Stoffels, G., Coenen, H. H., Kaiser, H. J., Langen, K., & Eble, M. J. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.01.055 · Cited by 143
Self-citationDynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients
Jansen, N. L., Suchorska, B., Wenter, V., Eigenbrod, S., Schmid‐Tannwald, C., Zwergal, A., Niyazi, M., Drexler, M., Bartenstein, P., Schnell, O., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.122333 · Cited by 141
von Schwarzenberg, J., Czernin, J. G., Cloughesy, T. F., Ellingson, B. M., Pope, W. B., Grogan, T., Elashoff, D. A., Geist, C. L., Silverman, D. H. S., Phelps, M. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1440 · Cited by 141
Lizárraga, K. J., Allen-Auerbach, M., Czernin, J. G., DeSalles, A. A. F., Yong, W. H., Phelps, M. E., & Chen, W. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.121418 · Cited by 140
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas
Galldiks, N., Kracht, L., Burghaus, L., Thomas, A., Jacobs, A. H., Heiss, W., & Herholz, K. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0002-5 · Cited by 139
Self-citationJain, R., Poisson, L., Narang, J., Gutman, D. A., Scarpace, L. M., Hwang, S. N., Holder, C. A., Wintermark, M., Colen, R. R., Kirby, J., et al. (2012) · Radiology · doi:10.1148/radiol.12120846 · Cited by 138
Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors
Kratochwil, C., Combs, S. E., Leotta, K., Afshar-Oromieh, A., Rieken, S., Debus, J., Haberkorn, U., & Giesel, F. L. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not199 · Cited by 133
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
Gerstner, E. R., Zhang, Z., Fink, J. R., Muzi, M., Hanna, L., Greco, E. M., Prah, M. A., Schmainda, K. M., Mintz, A., Kostakoglu, L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2529 · Cited by 132
Ceccon, G. S., Lohmann, P., Stoffels, G., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now149 · Cited by 132
Galldiks, N., Stoffels, G., Ruge, M. I., Rapp, M., Sabel, M., Reifenberger, G., Erdem, Z., Shah, N. J., Fink, G. R., Coenen, H. H., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.123836 · Cited by 131
Self-citationKebir, S., Fimmers, R., Galldiks, N., Schäfer, N., Mack, F., Schaub, C., Stuplich, M., Nießen, M., Tzaridis, T., Simon, M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1334 · Cited by 130
Self-citationEffective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
Pellegatta, S., Valletta, L., Corbetta, C., Patanè, M., Zucca, I., Sirtori, F. R., Bruzzone, M. G., Fogliatto, G., Isacchi, A., Pollo, B., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0180-0 · Cited by 127
Filß, C., Galldiks, N., Stoffels, G., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.129007 · Cited by 123
Self-citationTarget volumes in radiotherapy for high-grade malignant glioma of the brain
Jansen, E. P. M., Dewit, L. G. H., van Herk, M., & Bartelink, H. G. M. M. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00216-4 · Cited by 123
Schmainda, K. M., Prah, M. A., Connelly, J., Rand, S. D., Hoffman, R. G., Mueller, W. M., & Malkin, M. G. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not216 · Cited by 120
Svolos, P., Kousi, E., Kapsalaki, E. Z., Theodorou, K., Fezoulidis, I. V., Kappas, C., & Tsougos, I. (2014) · Cancer Imaging · doi:10.1186/1470-7330-14-20 · Cited by 115
Prognostic value of choline and creatine in WHO grade II gliomas
Hattingen, E., Raab, P., Franz, K., Lanfermann, H., Setzer, M., Gerlach, R., Zanella, F. E., & Pilatus, U. (2008) · Neuroradiology · doi:10.1007/s00234-008-0409-3 · Cited by 111
Self-citationWang, Q., Zhang, H., Zhang, J., Wu, C., Zhu, W., Li, F., Chen, X., & Xu, B. (2015) · European Radiology · doi:10.1007/s00330-015-4046-z · Cited by 110
Metabolic and molecular imaging in neuro-oncology
Herholz, K., Coope, D. J., & Jackson, A. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70192-8 · Cited by 107
The translocator protein ligand [18F]DPA-714 images glioma and activated microglia in vivo
Winkeler, A., Boisgard, R., Awde, A. R., Dubois, A., Thezé, B., Zheng, J., Ciobanu, L., Dollé, F., Viel, T., Jacobs, A. H., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-2041-4 · Cited by 104
Lehnhardt, F., Bock, C., Röhn, G., Ernestus, R., & Hoehn, M. (2005) · NMR in Biomedicine · doi:10.1002/nbm.968 · Cited by 97
Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma
Shiroishi, M. S., Boxerman, J. L., & Pope, W. B. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov179 · Cited by 93
Moulin-Romsee, G., D’Hondt, E., de Groot, T., et al. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0557-4 · Cited by 91
Su, Z., Roncaroli, F., Durrenberger, P. F., Coope, D. J., Karabatsou, K., Hinz, R., Thompson, G., Turkheimer, F., Janczar, K., du Plessis, D., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.151621 · Cited by 91
Minamimoto, R., Saginoya, T., Kondo, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132515 · Cited by 89
Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?
Pichler, R., Dunzinger, A., Wurm, G., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1457-6 · Cited by 88
Nowosielski, M., DiFranco, M. D., Putzer, D., Seiz, M., Recheis, W. A., Jacobs, A. H., Stockhammer, G., & Hutterer, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095830 · Cited by 84
Stadlbauer, A., Prante, O., Nimsky, C., Salomonowitz, E. K., Buchfelder, M., Kuwert, T., Linke, R., & Ganslandt, O. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049213 · Cited by 79
Thon, N., Kunz, M., Lemke, L., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29259 · Cited by 74
Ellingson, B. M., Sahebjam, S., Kim, H. J., Pope, W. B., Harris, R. J., Woodworth, D. C., Lai, A., Nghiemphu, P. L., Mason, W. P., & Cloughesy, T. F. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3748 · Cited by 74
TSPO expression in brain tumours: is TSPO a target for brain tumour imaging?
Roncaroli, F., Su, Z., Herholz, K., Gerhard, A., & Turkheimer, F. E. (2016) · Clinical and Translational Imaging · doi:10.1007/s40336-016-0168-9 · Cited by 74
[18F]-fluoro-l-thymidine PET and advanced MRI for preoperative grading of gliomas
Collet, S., Valable, S., Constans, J., Lechapt, E., Roussel, S., Delcroix, N., Abbas, A., Ibazizène, M., Bernaudin, M., Barré, L., et al. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.05.012 · Cited by 61
1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours
Hattingen, E., Lanfermann, H., Quick, J., Franz, K., Zanella, F. E., & Pilatus, U. (2008) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-008-0145-z · Cited by 55
Self-citationFayed, N. M., Dávila, J., Medrano, J., & Olmos, S. C. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.02.039 · Cited by 53
The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
Smits, A., & Baumert, B. G. (2011) · International Journal of Molecular Imaging · doi:10.1155/2011/372509 · Cited by 46
Galldiks, N., Dunkl, V., Kracht, L., Vollmar, S., Jacobs, A. H., Fink, G. R., & Schroeter, M. (2012) · Molecular Imaging · doi:10.2310/7290.2012.00022 · Cited by 46
Self-citationGalldiks, N., Rapp, M., Stoffels, G., et al. (2013) · Molecular Imaging · doi:10.2310/7290.2013.00051 · Cited by 42
Self-citationJensen, P., Feng, L., Law, I. G., Svarer, C., Knudsen, G. M., Mikkelsen, J. D., de Nijs, R., Larsen, V. A., Dyssegaard, A., Thomsen, G. K., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.158998 · Cited by 40
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.
Villani, V., Carapella, C. M., Chiaravalloti, A., et al. (2015) · PubMed · Cited by 38
Chung, C. D., Metser, U., & Ménard, C. M. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2015.02.002 · Cited by 38
Magnetic Resonance Spectroscopic Imaging for Visualization of the Infiltration Zone of Glioma
Stadlbauer, A., Buchfelder, M., Doelken, M. T., Hammen, T., & Ganslandt, O. (2010) · Central European Neurosurgery · doi:10.1055/s-0030-1253410 · Cited by 31
Rapp, M., Floeth, F. W., Felsberg, J., Steiger, H., Sabel, M., Langen, K., & Galldiks, N. (2013) · Neurosurgical FOCUS · doi:10.3171/2012.12.focus12336 · Cited by 26
Self-citation1H MRSI and progression-free survival in patients with WHO grades II and III gliomas
Hattingen, E., Delic, O., Franz, K., et al. (2009) · Neurological Research · doi:10.1179/016164109x12478302362770 · Cited by 24
Self-citationWagner, M., Nafe, R., Jurcoane, A., Pilatus, U., Franz, K., Rieger, J., Steinbach, J. P., & Hattingen, E. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0443-y · Cited by 18
Self-citationPerspectives of Ultra-High-Field MRI in Neuroradiology
Gizewski, E. R., Mönninghoff, C., & Forsting, M. (2015) · Clinical Neuroradiology · doi:10.1007/s00062-015-0437-4 · Cited by 15
Cited by
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
Recent Advances of Optical Imaging in the Second Near‐Infrared Window
Kenry, Duan, Y., & Liu, B. (2018) · Advanced Materials · doi:10.1002/adma.201802394 · Cited by 810
Law, I., Albert, N. L., Arbizu, J., Boellaard, R., Drzezga, A., Galldiks, N., la Fougère, C., Langen, K.-J., Lopci, E., Lowe, V., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4207-9 · Cited by 556
Self-citationSheng, Z., Guo, B., Hu, D., Xu, S., Wu, W., Liew, W. H., Yao, K., Jiang, J., Liu, C., Zheng, H., et al. (2018) · Advanced Materials · doi:10.1002/adma.201800766 · Cited by 445
Guo, B., Sheng, Z., Hu, D., Liu, C., Zheng, H., & Liu, B. (2018) · Advanced Materials · doi:10.1002/adma.201802591 · Cited by 431
Metadata
- Authors
- Langen, K.-J., Galldiks, N., Hattingen, E., & Shah, N. J.
- Venue
- Nature Reviews Neurology
- Published
- 2017-04-07
- Volume
- 13
- Issue
- 5
- Pages
- 279-289
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2605167804
- Cited by
- 339
- References
- 105
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.